Notice for Industry: Mandatory Reporting Requirement during the COVID-19 Pandemic

In light of the COVID-19 outbreak, Health Canada is clarifying expectations for manufacturers, importers and market authorization holders (MAHs) regarding requirement to report adverse reactions (ARs) and medical device problems (MDPs) during a pandemic.

Données et ressources

Info additionnelle

Champ Valeur
Dernière modification avril 17, 2026, 17:41 (TU)
Créé le avril 17, 2026, 17:41 (TU)
criticality_level []
geographic_scope []
open_canada_collection publication
open_canada_date_published 2020-04-03 00:00:00
open_canada_keywords {"fr": ["Avis à l'intention de l’industrie", "éclosion de la COVID-19", "pandémie"], "en": ["Notice for Industry", "COVID-19 outbreak", "pandemic"]}
open_canada_subject ["government_and_politics", "health_and_safety"]
sensitivity_level unrestricted
title_fr Avis à l'intention de l’industrie: exigence de déclaration obligatoire pendant la pandémie de la COVID-19
update_frequency unknown